Moomoo AI 已提取核心訊息
Eli Lilly and Co has successfully launched a substantial $6.5 billion notes offering, as detailed in their Free Writing Prospectus filed with the SEC under Rule 433. The offering, dated February 7, 2024, includes a series of notes with varying maturities: 2027, 2029, 2034, 2054, and 2064, each with a fixed annual coupon rate ranging from 4.500% to 5.100%. The trade date for the notes was February 7, 2024, with a settlement date of February 9, 2024. The notes received high credit ratings from Moody's (A1) and S&P (A+), both with stable outlooks. The joint book-running managers for the transaction included BofA Securities, Inc., Barclays Capital Inc., and Citigroup Global Markets Inc., among others. The offering was priced close to the principal amount, with yields to maturity slightly exceeding the coupon rates. The notes are redeemable at par after a specified date, with make-whole call provisions in place before that. The registration statement for the offering, No. 333-262943, is available on the SEC's website, and the prospectus can be obtained from the underwriters.
Eli Lilly and Co has successfully launched a substantial $6.5 billion notes offering, as detailed in their Free Writing Prospectus filed with the SEC under Rule 433. The offering, dated February 7, 2024, includes a series of notes with varying maturities: 2027, 2029, 2034, 2054, and 2064, each with a fixed annual coupon rate ranging from 4.500% to 5.100%. The trade date for the notes was February 7, 2024, with a settlement date of February 9, 2024. The notes received high credit ratings from Moody's (A1) and S&P (A+), both with stable outlooks. The joint book-running managers for the transaction included BofA Securities, Inc., Barclays Capital Inc., and Citigroup Global Markets Inc., among others. The offering was priced close to the principal amount, with yields to maturity slightly exceeding the coupon rates. The notes are redeemable at par after a specified date, with make-whole call provisions in place before that. The registration statement for the offering, No. 333-262943, is available on the SEC's website, and the prospectus can be obtained from the underwriters.
禮來公司成功發行了65億美元的巨額票據，詳見他們根據第433條向美國證券交易委員會提交的免費寫作招股說明書。此次發行日期爲2024年2月7日，包括一系列期限不同的票據：2027年、2029年、2034、2054和2064年，每張票據的固定年息率在4.500％至5.100％之間。這些票據的交易日期爲2024年2月7日，結算日期爲2024年2月9日。這些票據獲得了穆迪（A1）和標準普爾（A+）的高信用評級，前景均穩定。該交易的聯席賬面管理人包括美銀證券公司、巴克萊資本公司和花旗集團環球市場公司等。此次發行的價格接近本金，到期收益率略高於票面利率。這些票據可在指定日期之後按面值兌換，在此之前已制定了看漲期權條款。此次發行的註冊聲明編號爲333-262943，可在美國證券交易委員會的網站上查閱，招股說明書可以從承銷商處獲得。
禮來公司成功發行了65億美元的巨額票據，詳見他們根據第433條向美國證券交易委員會提交的免費寫作招股說明書。此次發行日期爲2024年2月7日，包括一系列期限不同的票據：2027年、2029年、2034、2054和2064年，每張票據的固定年息率在4.500％至5.100％之間。這些票據的交易日期爲2024年2月7日，結算日期爲2024年2月9日。這些票據獲得了穆迪（A1）和標準普爾（A+）的高信用評級，前景均穩定。該交易的聯席賬面管理人包括美銀證券公司、巴克萊資本公司和花旗集團環球市場公司等。此次發行的價格接近本金，到期收益率略高於票面利率。這些票據可在指定日期之後按面值兌換，在此之前已制定了看漲期權條款。此次發行的註冊聲明編號爲333-262943，可在美國證券交易委員會的網站上查閱，招股說明書可以從承銷商處獲得。
有用
沒用